- Home
- LYEL vs GDEV Comparison
LYEL vs GDEV Comparison
Compare LYEL & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$25.25
N/A
Current Price
$16.78
Company Overview
Basic Information| Metric | LYEL | GDEV |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.4M | 388.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LYEL | GDEV |
|---|---|---|
| Price | $25.25 | $16.78 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.67 | N/A |
| AVG Volume (30 Days) | ★ 44.4K | 6.3K |
| Earning Date | 11-12-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.98 |
| EPS | N/A | ★ 3.08 |
| Revenue | $41,000.00 | ★ $412,018,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.39 |
| P/E Ratio | ★ N/A | $5.50 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.65 | $8.60 |
| 52 Week High | $25.74 | $42.20 |
Technical Indicators
Market Signals| Indicator | LYEL | GDEV |
|---|---|---|
| Relative Strength Index (RSI) | 69.41 | 40.84 |
| Support Level | $20.59 | $17.21 |
| Resistance Level | $25.20 | $25.03 |
| Average True Range (ATR) | 2.03 | 1.72 |
| MACD | 0.48 | -0.25 |
| Stochastic Oscillator | 95.62 | 6.04 |
Price Performance
Historical Comparison LYEL
GDEV
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.